We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDLS icon
3826
Noodles & Co
NDLS
$107M
$15K ﹤0.01%
319
-196
-38% -$12K
ACH
3827
Accendra Health
ACH
$73.1M
$15K ﹤0.01%
347
-15,585
-98% -$669K
PKX icon
3828
POSCO
PKX
$17.7B
$15K ﹤0.01%
249
-11,244
-98% -$663K
PRLB icon
3829
Protolabs
PRLB
$2.2B
$15K ﹤0.01%
285
-3,178
-92% -$167K
PRSO icon
3830
Peraso
PRSO
$10.2M
$15K ﹤0.01%
173
+172
+17,200% +$18.4K
PSET icon
3831
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$29.3M
$15K ﹤0.01%
+276
New +$15.1K
QUAD icon
3832
Quad
QUAD
$513M
$15K ﹤0.01%
+2,117
New +$11.1K
ROM icon
3833
ProShares Ultra Technology
ROM
$1.32B
$15K ﹤0.01%
295
-13,455
-98% -$669K
SANM icon
3834
Sanmina
SANM
$11.3B
$15K ﹤0.01%
377
-449
-54% -$17.9K
SGRY icon
3835
Surgery Partners
SGRY
$1.97B
$15K ﹤0.01%
272
-98
-26% -$4.85K
SPTI icon
3836
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$15K ﹤0.01%
479
-9,033
-95% -$282K
SPXC icon
3837
SPX Corp
SPXC
$10.9B
$15K ﹤0.01%
296
-5,129
-95% -$265K
TBPH icon
3838
Theravance Biopharma
TBPH
$881M
$15K ﹤0.01%
1,534
-215
-12% -$2.11K
TXMD icon
3839
TherapeuticsMD
TXMD
$24M
$15K ﹤0.01%
803
+296
+58% +$4.66K
UONE icon
3840
Urban One Class A
UONE
$23.3M
$15K ﹤0.01%
250
-52
-17% -$2.79K
USNA icon
3841
Usana Health Sciences
USNA
$247M
$15K ﹤0.01%
191
+54
+39% +$4.87K
VOE icon
3842
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
$15K ﹤0.01%
100
-1,636
-94% -$241K
XGN icon
3843
Exagen
XGN
$161M
$15K ﹤0.01%
1,929
+962
+99% +$8.29K
ATXI
3844
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$15K ﹤0.01%
29
+10
+53% +$7.47K
PLMJU
3845
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
$15K ﹤0.01%
1,519
-30
-2% -$294
MMV
3846
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
$15K ﹤0.01%
+1,520
New +$15.3K
DLA
3847
DELISTED
Delta Apparel Inc.
DLA
$15K ﹤0.01%
514
-614
-54% -$18.3K
TRVN
3848
DELISTED
Trevena, Inc.
TRVN
$15K ﹤0.01%
44
+21
+91% +$6.63K
APACU
3849
DELISTED
StoneBridge Acquisition Corporation Unit
APACU
$15K ﹤0.01%
1,469
-1,708
-54% -$17.3K
ICVX
3850
DELISTED
Icosavax, Inc. Common Stock
ICVX
$15K ﹤0.01%
2,135
+575
+37% +$9.04K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.